SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Byers PH 2002 Osteogenesis imperfecta. In: RoycePM, SteinmannB (eds.) Connective Tissue and Its Heritable Disorders, 2nd ed. Wiley-Liss, Inc., New York, NY, USA, pp. 385430.
  • 2
    Kuivaniemi H, Tromp G, Prockop DJ 1991 Mutations in collagen genes: Causes of rare and some common diseases in humans. FASEB J 5:20522060.
  • 3
    Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ 2000 Type V osteogenesis imperfecta: A new form of brittle bone disease. J Bone Miner Res 15:16501658.
  • 4
    Labuda M, Morissette J, Ward LM, Rauch F, Lalic L, Roughley PJ, Glorieux FH 2002 Osteogenesis imperfecta type VII maps to the short arm of chromosome 3. Bone 31:1925.
  • 5
    Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, Roughley PJ, Glorieux FH 2002 Osteogenesis imperfecta type VII: An autosomal recessive form of brittle bone disease. Bone 31:1218.
  • 6
    Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R 2002 Osteogenesis imperfecta type VI: A form of brittle bone disease with a mineralization defect. J Bone Miner Res 17:3038.
  • 7
    Marini JC 1988 Osteogenesis imperfecta: Comprehensive management. Adv Pediatr 35:391426.
  • 8
    Bonadio J, Saunders TL, Tsai E, Goldstein SA, Morris-Wiman J, Brinkley L, Dolan DF, Altschuler RA, Hawkins JE Jr, Bateman JF 1990 Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci USA 87:71457149.
  • 9
    Chipman SD, Sweet HO, McBride DJ Jr, Davisson MT, Marks SC Jr, Shuldiner AR, Wenstrup RJ, Rowe DW, Shapiro JR 1993 Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: A model of human osteogenesis imperfecta. Proc Natl Acad Sci USA 90:17011705.
  • 10
    Saban J, Zussman MA, Havey R, Patwardhan AG, Schneider GB, King D 1996 Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta. Bone 19:575579.
  • 11
    Khillan JS, Olsen AS, Kontusaari S, Sokolov B, Prockop DJ 1991 Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta. J Biol Chem 266:2337323379.
  • 12
    Forlino A, Porter FD, Lee EJ, Westphal H, Marini JC 1999 Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an α1(I) G349C substitution. Variability in phenotype in BrtlIV mice. J Biol Chem 274:3792337931.
  • 13
    Sarafova AP, Choi H, Forlino A, Gajko A, Cabral WA, Tosi L, Reing CM, Marini JC 1998 Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen. Hum Mutat 11:395403.
  • 14
    Feldkamp LA, Goldstein SA, Parfitt AM, Jesion G, Kleerekoper M 1989 The direct examination of three-dimensional bone architecture in vitro by computed tomography. J Bone Miner Res 4:311.
  • 15
    Kuhn JL, Goldstein SA, Feldkamp LA, Goulet RW, Jesion G 1990 Evaluation of a microcomputed tomography system to study trabecular bone structure. J Orthop Res 8:833842.
  • 16
    Goulet RW 1993 The quantification of the structure and mechanical properties of trabecular bone. Ph.D. thesis, University of Michigan, Ann Arbor, MI.
  • 17
    Turner CH, Burr DB 1993 Basic biomechanical measurements of bone: A tutorial. Bone 14:595608.
  • 18
    Carden A, Morris MD 2000 Application of vibrational spectroscopy to the study of mineralized tissues. J Biomed Opt 5:259268.
  • 19
    Choi K, Goldstein SA 1992 A comparison of the fatigue behavior of human trabecular and cortical bone tissue. J Biomech 25:13711381.
  • 20
    Kuhn JL, Goldstein SA, Choi K, London M, Feldkamp LA, Matthews LS 1989 Comparison of the trabecular and cortical tissue moduli from human iliac crests. J Orthop Res 7:876884.
  • 21
    Jepsen KJ, Schaffler MB, Kuhn JL, Goulet RW, Bonadio J, Goldstein SA 1997 Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue. J Biomech 30:11411147.
  • 22
    Carden A, Rajachar RM, Morris MD, Kohn DH 2003 Ultrastructural changes accompanying the mechanical deformation of bone tissue: A Raman imaging study. Calcif Tissue Int 72:166175.
  • 23
    Pezzuti JA, Morris MD, Bonadio JF, Goldstein SA 1998 Hyperspectral Raman imaging of bone growth and regrowth chemistry. Proc SPIE 3261:270276.
  • 24
    Timlin JA, Carden A, Morris MD, Bonadio JF, Hoffler CE, Kozloff KM, Goldstein SA 1999 Spatial distribution of phosphate species in mature and newly generated mammalian bone by hyperspectral Raman imaging. J Biomed Opt 4:2834.
  • 25
    Timlin JA, Carden A, Morris MD, Rajachar RM, Kohn DH 2000 Raman spectroscopic imaging markers for fatigue-related microdamage in bovine bone. Anal Chem 72:22292236.
  • 26
    Malinowski ER 1991 Factor Analysis in Chemistry, 2nd ed. John Wiley & Sons, Inc., New York, NY, USA.
  • 27
    Reyment R, Joreskog KG 1996 Applied Factor Analysis in the Natural Sciences. Cambridge University Press, New York, NY, USA.
  • 28
    Morris MD, Crane NJ, Gomez LE, Ignelzi MA Jr 2004 Compatibility of staining protocols for bone tissue with Raman imaging. Calcif Tissue Int (in press)
  • 29
    Tarnowski CP, Ignelzi MA Jr, Morris MD 2002 Mineralization of developing mouse calvaria as revealed by Raman microspectroscopy. J Bone Miner Res 17:11181126.
  • 30
    Freeman JJ, Wopenka B, Silva MJ, Pasteris JD 2001 Raman spectroscopic detection of changes in bioapatite in mouse femora as a function of age and in vitro fluoride treatment. Calcif Tissue Int 68:156162.
  • 31
    de Mul FF, Hottenhuis MH, Bouter P, Greve J, Arends J, ten Bosch JJ 1986 Micro-Raman line broadening in synthetic carbonated hydroxyapatite. J Dent Res 65:437440.
  • 32
    Ferguson VL, Ayers RA, Bateman TA, Simske SJ 2000 Development of endogenous osteoporosis in male C57BL/6J mice. J Bone Miner Res 15:S461.
  • 33
    McBride DJ Jr, Shapiro JR, Dunn MG 1998 Bone geometry and strength measurements in aging mice with the oim mutation. Calcif Tissue Int 62:172176.
  • 34
    Silva MJ, Brodt MD, Ettner SL 2002 Long bones from the senescence accelerated mouse SAMP6 have increased size but reduced whole-bone strength and resistance to fracture. J Bone Miner Res 17:15971603.
  • 35
    Schnieke A, Dziadek M, Bateman J, Mascara T, Harbers K, Gelinas R, Jaenisch R 1987 Introduction of the human pro alpha 1(I) collagen gene into pro alpha 1(I)-deficient Mov-13 mouse cells leads to formation of functional mouse-human hybrid type I collagen. Proc Natl Acad Sci USA 84:764768.
  • 36
    Jepsen KJ, Goldstein SA, Kuhn JL, Schaffler MB, Bonadio J 1996 Type-I collagen mutation compromises the post-yield behavior of Mov13 long bone. J Orthop Res 14:493499.
  • 37
    Bonadio J, Jepsen KJ, Mansoura MK, Jaenisch R, Kuhn JL, Goldstein SA 1993 A murine skeletal adaptation that significantly increases cortical bone mechanical properties. Implications for human skeletal fragility. J Clin Invest 92:16971705.
  • 38
    Camacho NP, Hou L, Toledano TR, Ilg WA, Brayton CF, Raggio CL, Root L, Boskey AL 1999 The material basis for reduced mechanical properties in oim mice bones. J Bone Miner Res 14:264272.
  • 39
    Bohic S, Heymann D, Pouezat JA, Gauthier O, Daculsi G 1998 Transmission FT-IR microspectroscopy of mineral phases in calcified tissues. Comptes Rendus de l'Academie des Sciences Serie III, Sciences de la Vie 321:865876.
  • 40
    Camacho NP, Landis WJ, Boskey AL 1996 Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy. Connect Tissue Res 35:259265.
  • 41
    Vetter U, Eanes ED, Kopp JB, Termine JD, Robey PG 1991 Changes in apatite crystal size in bones of patients with osteogenesis imperfecta. Calcif Tissue Int 49:248250.
  • 42
    Fratzl P, Paris O, Klaushofer K, Landis WJ 1996 Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering. J Clin Invest 97:396402.
  • 43
    McKee MD, Nanci A 1995 Postembedding colloidal-gold immunocytochemistry of noncollagenous extracellular matrix proteins in mineralized tissues. Microsc Res Tech 31:4462.
  • 44
    Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM 1999 Anabolic effects of human biosynthetic parathyroid hormone fragment (1–34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 14:536545.
  • 45
    Wronski TJ, Yen CF 1994 Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15:5158.
  • 46
    Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study. J Bone Miner Res 16:18461853.
  • 47
    Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ 1997 Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 100:14751480.
  • 48
    Meunier PJ, Boivin G 1997 Bone mineral density reflects bone mass but also the degree of mineralization of bone: Therapeutic implications. Bone 21:373377.
  • 49
    Bourrin S, Ammann P, Bonjour JP, Rizzoli R 2002 Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats. Bone 30:195200.
  • 50
    Camacho NP, Raggio CL, Doty SB, Root L, Zraick V, Ilg WA, Toledano TR, Boskey AL 2001 A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta. Calcif Tissue Int 69:94101.